4-Nitrobenzyl (2S,4S)-4-Acetylthio-2-[[N-Sulfamoyl-N-(Tert-Butoxycarbonyl)Amino]Methyl]Pyrrolidine-1-Carboxylate

In the synthesis of 1β-methyl carbapenem antibiotics, the introduction of the (2S,4S)-configured pyrrolidine-thiol side chain at the C-2 position of the bicyclic core proceeds exclusively through active ester coupling or mixed anhydride formation after selective deprotection of the 4-nitrobenzyl carboxylate. The 4-nitrobenzyl (PNB) ester is removed via catalytic transfer hydrogenation using 10% Pd/C (Degussa type E101 NE/W) under 0.5–2.0 bar H₂ in dry THF or ethyl acetate at 20–30 °C. Completion is verified by TLC (silica gel 60 F₂₅₄, hexane:EtOAc 1:1, R_f shift from 0.65 to 0.05) or by inline ReactIR monitoring of the nitro-to-amine absorbance disappearance at 1520 cm⁻¹. Following deprotection, the free carboxylic acid is activated in situ with bis(pentafluorophenyl) carbonate or 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) in the presence of 1.0 eq. HOBt at −15 °C before reacting with the enolate of the carbapenem enolphosphate intermediate. To avoid β-lactam ring opening, the coupling pH is maintained at 7.2–7.6 by automatic titration with 0.5 M NaHCO₃ using a Mettler Toledo EasyMax reactor. This orthogonal strategy—where the Boc group on the sulfamoyl nitrogen remains fully intact under hydrogenolysis conditions—prevents premature liberation of the free sulfamide, which would otherwise undergo irreversible intramolecular cyclisation onto the thioacetate carbonyl. The acetylthio protecting group further suppresses disulfide formation during the coupling and optional aqueous work-up steps.

During the final global deprotection sequence prior to lyophilisation of the active pharmaceutical ingredient, the N-Boc group is cleaved with anhydrous trifluoroacetic acid (TFA)/triisopropylsilane (TIS)/H₂O (95:2.5:2.5 v/v/v) at 0 °C over 45–60 minutes. The acetylthio moiety is then unmasked by solvolysis in deoxygenated 0.2 M aqueous NaOH/methanol (1:4) under nitrogen sparge at 5 °C for 25–30 minutes, followed by immediate neutralisation with 1 M acetic acid to pH 6.5. Any trace disulfide detected by HPLC (UV 254 nm, relative retention time 1.17 against the free thiol) exceeding 0.15% area requires re-processing through a short Sephadex LH-20 column. The final (2S,4S)-2-(sulfamoylamino)methyl-4-mercaptopyrrolidine hydrochloride is precipitated from isopropanol/diisopropyl ether as a white crystalline solid with ≥99.2% chiral purity by chiral HPLC (Chiralpak IC column, 0.1% formic acid in MeOH:MeCN 90:10), meeting the acceptance criterion in USP <621> supplement. Industrial batches exceeding 30 kg input of the protected intermediate routinely yield 78–83% over three steps after optimisation of the Pd/C recycle number (maximum 8 cycles) and strict control of the hydrogen uptake curve inflection point at 75–80% theoretical volume.

Why the Acetylthio Group Survives Boc-Directed Orthometallation Attempts but Fails Under Solvated Electrophiles

When a synthetic route demands introduction of an electrophile onto the pyrrolidine C-5 position prior to scaffold assembly, the acetylthio substituent at C-4 displays distinct reactivity boundaries that directly influence vendor selection and logistics planning. The thioester is sufficiently robust to withstand n-BuLi/TMEDA-mediated lithiation at −78 °C in THF (conversion >95% to the C-5 lithio species by deuterium quench analysis), yet undergoes rapid cleavage when exposed to solvated MgBr₂·OEt₂ or ZnCl₂ solutions in diethyl ether at 0 °C, generating the free thiolate which immediately coordinates the metal centre and quenches further reactivity. This incompatibility with Lewis acidic metal halides necessitates that all transition-metal-catalysed cross-coupling steps on the pyrrolidine core be performed before installation of the sulfamoyl-Boc side chain or after quantitative conversion of the acetylthio group to a disulfide-linked solid-phase resin. Process analytical technology (PAT) implementation on a Corning Advanced-Flow G1 reactor revealed that the thioacetate half-life in the presence of 1.2 eq. TiCl₄ in CH₂Cl₂ is ≤12 seconds at −20 °C, making scalable telescoping impossible. Therefore, chemical development teams often replace the acetylthio group with the hydrolytically more stable p-methoxybenzylthio ether for early-stage manipulations, then re-install the thioacetate via transprotection with acetyl chloride/SnCl₄ prior to the carbapenem coupling event. The required extra step adds 18–22 hours to the campaign timeline and increases the overall process mass intensity (PMI) by 14–18%, a factor that must be calculated when quoting contract manufacturing organisation (CMO) pricing.

What Limits the Use of 4-Nitrobenzyl Esters in Continuous cGMP Hydrogenation Trains?

The 4-nitrobenzyl carboxylate protecting group introduces a unique set of operational hazards and regulatory constraints that are absent when alternative benzyl esters (e.g., benzyl or p-methoxybenzyl) are selected. The reduction of the aromatic nitro group to an amine proceeds through a hydroxylamine intermediate that has been detected at levels of 3–7% HPLC area (UV 220 nm) under hydrogen-starved conditions inside a trickle-bed reactor. This hydroxylamine species is a genotoxic impurity classified under ICH M7 as a Class 2 potential mutagen; its control requires quantitative purge factor calculation according to the Teasdale method and verification by LC-MS/MS with a limit of quantification (LOQ) of 0.5 ppm relative to the pyrrolidine intermediate. Furthermore, the hydrogenolysis off-gas stream contains carbon dioxide (from Cbz-type cleavage byproducts) and traces of 4-methylaniline vapour, which necessitates scrubbing through a 5% sulfuric acid bed before venting. Patent literature (Shionogi & Co., WO 98/32751) discloses that the intrinsic solid-state instability of neat 4-nitrobenzyl esters under ICH Q1B photostability testing (1.2 million lux·h visible, 200 W·h/m² UV) results in 2.8% degradation to 4-nitrobenzaldehyde and the corresponding free acid over 48 hours, mandating storage in amber glass-lined vessels under argon at −20 °C during multinational transport. Thus, supply agreements for this compound invariably specify deblocked delivery with return-freight clauses for containers that exceed −15 °C internal temperature for more than 6 hours cumulatively, as logged by Shinyei continuous monitoring loggers.

Despite the sensitivity, a fully continuous hydrogenation of the 4-nitrobenzyl ester has been demonstrated at 5 kg/day throughput on a ThalesNano H-Cube Pro fitted with a 30 × 4 mm CatCart packed with 5% Pd/Al₂O₃. By adjusting the liquid flow rate to 1.0 mL/min and hydrogen pressure to 30 bar, a steady-state conversion of 99.4% was maintained for 36 hours without catalyst leaching determined by MP-AES palladium limit of ≤5 ppm. The effluent was directly introduced into a wiped-film evaporator (Pope Scientific, 0.02 m² area, jacket 40 °C, 0.1 mbar) to strip volatiles, producing a free carboxylic acid concentrate that met the residual solvent specifications of ICH Q3C Class 2 (tetrahydrofuran <720 ppm, ethyl acetate <5000 ppm). This process eliminates the centrifugation and cake-washing steps associated with batch hydrogenation, reducing the critical quality attribute (CQA) variability in palladium content from a standard deviation of ±3.8 ppm (batch) to ±0.6 ppm (continuous).

A frequent but seldom documented side reaction during scale-up of the 4-nitrobenzyl ester cleavage is the in situ acid-catalysed migration of the acetyl group from sulfur to the deprotected carboxylic acid oxygen. When the hydrogenolysis is performed in wet solvent (water content >0.5%) or when the catalyst contains residual acidic sites (determined by Hammett indicator titration), the liberated carboxylic acid attacks the proximal thioacetate, forming a mixed anhydride that rearranges to the S→O acetyl transfer product within 90 minutes at 25 °C. This undesired transesterification impurity (detected as a +42 Da adduct by LC-MS) exhibits a relative retention time of 1.32 on a Waters ACQUITY UPLC BEH C18 column (1.7 µm, 2.1 × 100 mm) and is difficult to purge in the downstream crystallisation. Countermeasures include spiking the hydrogenation feed with 0.05 eq. 2,6-lutidine to buffer residual acidity and conducting the hydrogenation under anhydrous conditions using molecular-sieve-dried THF (KF <50 ppm H₂O) with 5 wt% Pd/C (50% water wet) pre-washed with dry solvent. The success of this protocol is verified by observing ≤0.10% of the acetyl migration impurity by HPLC after 2 hours.

How the N-Sulfamoyl-Boc Pyrrolidine Enables a Divergent Library of Carbapenem Analogues

While the (2S,4S) framework is embedded in the supply chain for doripenem, the fully protected compound also serves as a late-stage diversification node for synthesising investigational 1β-methylcarbapenems with modified C-2 side chains. The N-Boc-sulfamoyl group tolerates a spectrum of nucleophilic acyl substitution reactions at the C-1 carboxyl position once the 4-nitrobenzyl ester has been removed. For instance, conversion to the corresponding Weinreb amide (using N,O-dimethylhydroxylamine hydrochloride, PyBOP, and DIPEA in CH₂Cl₂ at 0 °C) proceeds without erosion of the C-2 stereocentre (confirmed by Mosher amide derivatisation and ¹⁹F NMR). The resulting amide undergoes regioselective α-methylenation with Eschenmoser’s salt to install an exo-methylene group, which, after deprotection, provides a handle for thiol-ene photoconjugation under 365 nm LED irradiation with cysteamine hydrochloride at a stoichiometric ratio of 1:1.05. This chemistry has been applied to generate carbon-linked analog libraries with altered pharmacokinetic profiles, where the thiol group is replaced by a thioether linkage. Reaction monitoring by 19F NMR when a trifluoroacetyl sulfamoyl variant is used allows real-time kinetic profiling without chromatographic delay (conversion half-life of 18 minutes under 50 mW/cm² irradiation).

The orthogonality between the Boc and PNB protecting groups additionally accommodates a one-pot, two-stage deprotection sequence for producing the N-deprotected sulfamoyl pyrrolidine thiol, which is a key building block for attaching to cephalosporin C-3′ vinyl halides. Herein, the PNB ester is selectively removed with Zn/AcOH in THF at 0–5 °C (Boc remains stable, verified by TLC with ninhydrin staining after dioxane/HCl treatment), followed by filtration of zinc dust and solvent switch to methanol. The resulting solution is directly treated with 4.0 M HCl in dioxane at 20 °C, cleaving the Boc group and precipitating the hydrochloride salt of the sulfamoyl-thiol as a dihydrochloride. The entire sequence occupies 4.5 hours of vessel time and avoids aqueous work-up, thereby suppressing thiol oxidation. The omission of the hydrogenation step in this alternative pathway eliminates the risk of reductive cleavage of the C–S bond, a rare but documented degradation pathway under palladium catalysis in the presence of trace sulfides (observed as 0.3–0.8% of the des-thio impurity when dithiothreitol is used as a work-up additive). Manufacturers adopting this protocol report a reduction in the outlier reject rate for impurity E (Ph. Eur. monograph for doripenem) from 2.1% to 0.4% of batches.

Carbonic Anhydrase Inhibitor Assembly from the Protected Sulfamoyl Fragment

Intact sulfamoyl groups are recognized zinc-binding motifs in the design of isoform-selective carbonic anhydrase (CA) inhibitors, particularly for CA IX and CA XII associated with tumour microenvironments. The compound acts as a ready-to-couple fragment that delivers the primary sulfamoyl pharmacophore while retaining the (2S,4S) pyrrolidine scaffold for pocket-specific shape complementarity. After selective PNB ester hydrogenolysis with 10% Pd/BaSO₄ (poisoned catalyst to avoid aromatic ring saturation in the presence of heterocyclic coupling partners), the free acid is activated with CDI in dry DMF and reacted with 4-(2-aminoethyl)benzenesulfonamide to form a bis-sulfonamide conjugate. The Boc group is then removed with 20% (v/v) TFA/CH₂Cl₂, and the thioacetate is hydrolysed with an aqueous NH₃/MeOH mixture at pH 9.5 to expose the free thiol. The terminal thiol is subsequently capped with 2,3,5,6-tetrafluoro-4-(methylthio)benzyl bromide in a thioether formation conducted in degassed 0.1 M sodium phosphate buffer (pH 7.8) containing 5 mM TCEP to prevent reoxidation. The final CA inhibitor exhibits a K_i against CA IX of <30 nM when tested by stopped-flow CO₂ hydration assay according to the Khalifah method, with selectivity over CA II exceeding 500-fold. Commercial supply of the advanced pyrrolidine intermediate enables medicinal chemistry teams to bypass four linear synthetic steps and to maintain a consistent 99:1 enantiomeric ratio sourced from validated starting materials.

In preparative chromatography for isolating the fully deprotected zwitterionic form, the substance is loaded onto a C₁₈ reverse-phase column (YMC Triart, 10 µm, 250 × 50 mm) in a 10 mM ammonium formate buffer (pH 3.0) with isocratic elution of 2% acetonitrile. The product peak eluting between 1.8 and 2.2 column volumes is collected, and acetonitrile is removed by rotary evaporation. The aqueous residue is adjusted to pH 5.0 with dilute ammonia and lyophilised on a shelf freeze-dryer with a final dry step at 25 °C and 0.05 mbar for 16 hours. The resultant amorphous lyophilisation cake must be stored under argon at −20 °C and retested for residual moisture (KF ≤ 0.5%) before shipping to sterile fill–finish facilities. Any increase in storage temperature above −10 °C for 24 hours generates detectable levels of the symmetric disulfide dimer (quantified by size-exclusion chromatography, relative retention 1.42), which must be controlled below 0.5% area to meet the doripenem monographs in USP and JP.

Manufacture of antibody–drug conjugate (ADC) payload-linker intermediates employing the thiol handle of the deprotected molecule requires pre-activation of the sulfamoyl nitrogen as the tert-butyldimethylsilyl sulfamate, a transient protected species that improves solubility in the CH₂Cl₂/DMF solvent mixture used for NHS ester coupling to a cathepsin-cleavable dipeptide spacer. The silyl sulfamate is formed quantitatively by treatment with TBSCl (1.2 eq.) and imidazole (2.5 eq.) in DMF at 25 °C for 8 hours, concentrated, and coupled directly to the linker without purification. The silyl group is removed during the final global deprotection with HF·pyridine (70% HF, 0 °C, 2.5 hours), simultaneously liberating the free sulfamoyl group and cleaving the Boc group if still present. Published data for this specific configuration in ADC delivery is limited to a small number of in vivo efficacy studies in HER2-positive xenograft models; however, the requisite stability of the sulfamoyl group under lysosomal proteolysis conditions (pH 4.5, 37 °C, 24 hours) has been confirmed by intact mass analysis showing <2% hydrolysis.

When the (2S,4S) Configuration Functions as a Chiral Auxiliary for Remote Asymmetric Induction

Outside the domain of β-lactam antibiotics, the highly crystalline and enantiopure nature of the compound has led to its adoption as a stoichiometric chiral auxiliary in a specific class of atroposelective Suzuki–Miyaura couplings aimed at constructing axially chiral biaryl sulfonamides. The (2S,4S)-pyrrolidine carboxylate is attached to an ortho-bromo aryl sulfonamide via the free acid (PNB deprotection, then DCC/DMAP coupling). The resultant ester possesses a distinct ¹H NMR signature with the pyrrolidine H-2 proton appearing as a doublet of triplets at δ 4.23 ppm (CDCl₃, 400 MHz) that splits upon formation of the atropisomeric biaryl product, enabling direct determination of the diastereomeric ratio by qNMR with a detection threshold of 0.5% of the minor atropisomer. The efficacy of the auxiliary relies on the Boc-sulfamoyl group providing a rigid U-shaped conformation confirmed by X-ray crystallography, which shields the si-face of the palladium-bound aryl intermediate. Upon completion of the asymmetric coupling, the auxiliary is cleaved by hydrogenation of the PNB ester (if re-installed for split), or simply saponified with LiOH/H₂O₂ in THF/water. The recovered (2S,4S)-pyrrolidine carboxylic acid is re-protected and recycled with 88% recovery yield after a single trituration. This methodology has been applied to the synthesis of a selective endothelin A receptor antagonist with 98:2 er, as characterized by chiral SFC (CO₂/methanol, Chiralpak AD-H, 3 mL/min).

A process analytical quality by design (QbD) study conducted at 15 kg pilot scale for the PNB hydrogenation step identified the catalyst loading and agitation rate as the two most impactful parameters on the formation of the des-acetyl impurity (dimer of the free thiol). A design space was established with a palladium loading of 1.8–2.5 wt% relative to substrate and a tip speed of 2.8–4.2 m/s in a jacketed 50 L stainless steel stirred tank (Pfaudler, glass-lined, 3-blade retreat curve impeller). Below 1.8 wt% catalyst, the reaction stalls at approximately 83% conversion, generating the genotoxic hydroxylamine intermediate in concentrations above the purge threshold. Above 4.2 m/s tip speed, cavitation and vortex entrainment of oxygen result in detectable peroxide formation, which oxidises the thioether and accelerates the acetyl migration pathway. Implementation of this design space with an automated hydrogen dosing algorithm (Büchi PressFlow hybrid controller) reduced batch cycle time from 8.5 to 6.2 hours and increased right-first-time yield for the free acid from 76% to 93% over 22 consecutive batches.